Описанные в настоящем документе биспецифические белки, связывающиеся с BAFF и B7RP1, могут быть использованы в качестве терапевтических средств от целого ряда ""нарушений, особенно заболеваний"", вызванных аутоантителами и/или заболеваний, опосредованных и Т-клетками, и B-клетками.
Помогите, пожалуйста, перевести indications и conditions

Заранее спасибо!

...can be used as therapeutics for a variety of indications, particularly conditions driven by... -- ...могут использоваться для лечения по целому ряду показаний и, в частности, [для лечения] состояний, вызванных...

Such "conditions" include, for example, SLE, lupus, nephritis, ANCA-positive vasculitis, rheumatoid arthritis (RA), dermatomyositis, polymyositis, gastrointestinal diseases such as Crohn’s disease, ulcerative colitis, and celiac disease, skin conditions such as pemphigus, pemphigoid, and subacute cutaneous lupus erythematosus (SCLE), diseases of the nervous system such as multiple sclerosis and chronic inflammatory demyelinating polyneuropathy (CIDP), neuromuscular diseases such as myasthenia gravis, diseases involving the kidneys such as Goodpasture’s syndrome and glomerulonephritis, hematologic conditions such as autoimmune hemolytic anemia (AIHA), idiopathic thrombocytopenic purpura (ITP), and autoimmune neutropenia, liver conditions such as chronic active hepatitis and primary biliary cirrhosis, Sjogren’s syndrome, systemic sclerosis, and endocrine conditions including Hashimoto’s thyroiditis, Graves’ disease, Addison’s disease, and multiple endocrine autoimmune failure (commonly including diabetes, hypothyroidism, Addison’s disease, and gonadal failure).